Fiche centre
Rigshospitalet Glostrup
Glostrup Municipality — Denmark
Essais liés8clinical trials
VilleGlostrup Municipalitylocalisation
PaysDenmarklocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06284629
Essais cliniques associés
8| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Neptune | Parkinson | Non applicable | NCT06284629 | PD-DigiCare — Enhancing Referral Decision-making for Advanced Treatment in Parkinson's Disease Through Objective Measurements and Patient Reported Outcomes. | ACTIVE_NOT_RECRUITING |
| Ocrelizumab | SEP | Phase 3 | NCT03599245 | This is an Extension Study of the Roche P-trials to Investigate Safety and Effectiveness of Ocrelizumab in Participants With Multiple Sclerosis (MS) | COMPLETED |
| Feraheme | Migraine | Non applicable | NCT02549898 | Investigation of Vascular Inflammation in Migraine Using Molecular Nano-imaging and Black Blood Imaging MRI | COMPLETED |
| Ocrelizumab | SEP | Phase 3 | NCT04544436 | MUSETTE — A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS) | ACTIVE_NOT_RECRUITING |
| Substance P | Migraine | Non applicable | NCT06959004 | Substance P-Induced Migraine Attacks Without Aura | RECRUITING |
| Calcitonin-gene related peptide (CGRP) | Migraine | Non applicable | NCT07021859 | Induction of Migraine Attacks With Aura Using Calcitonin Gene-Related Peptide | RECRUITING |
| Ocrelizumab | SEP | Phase 3 | NCT04548999 | GAVOTTE — A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS) | ACTIVE_NOT_RECRUITING |
| Amylin | Migraine | Non applicable | NCT07340788 | Amylin-Induced Migraine Attacks Without Aura | NOT_YET_RECRUITING |